Nuwellis (NUWE) Cost of Revenue (2016 - 2026)
Nuwellis' (NUWE) quarterly Cost of Revenue came in at $471000.0 in Q2 2026, down 38.59% on a YoY basis from $767000.0 in Q2 2025, and down 34.49% quarter-over-quarter from $719000.0 in Q1 2026.
Analysis
Nuwellis (NUWE) Cost of Revenue (2016 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Cost of Revenue for 11 consecutive years, with $471000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cost of Revenue fell 38.59% year-over-year to $471000.0; the trailing twelve-month figure through Jun 2026 stood at $2.7 million (down 16.76% YoY), and the FY2025 full-year result was $3.1 million, up 2.68% from the prior year.
- Cost of Revenue declined to $471000.0 in Q2 2026 per NUWE's latest filing, from $719000.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $1.2 million in Q4 2023 and bottomed at $471000.0 in Q2 2026.
- Historically, Cost of Revenue has averaged $837166.7 across 5 years, with a median of $789000.0 in 2022.
- The sharpest annual moves came in 2022 and 2026: Cost of Revenue soared 34.76% in 2022, then plunged 38.59% in 2026.
- Over 5 years, Cost of Revenue stood at $1.0 million in 2022, then grew by 15.38% to $1.2 million in 2023, then declined by 16.85% to $967000.0 in 2024, then decreased by 20.37% to $770000.0 in 2025, then slumped by 38.83% to $471000.0 in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods registered $471000.0, $719000.0, and $770000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 931.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 3.42 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 2.09 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 1.59 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 392.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 18.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 478.40 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | 471,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 471,000.00 |
| Mar 31, 2026 | 719,000.00 |
| Dec 31, 2025 | 770,000.00 |
| Sep 30, 2025 | 772,000.00 |
| Jun 30, 2025 | 767,000.00 |
| Mar 31, 2025 | 837,000.00 |
| Dec 31, 2024 | 967,000.00 |
| Sep 30, 2024 | 711,000.00 |
| Jun 30, 2024 | 720,000.00 |
| Mar 31, 2024 | 666,000.00 |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 928,000.00 |
| Mar 31, 2023 | 759,000.00 |
| Dec 31, 2022 | 1.01 Mn |
| Sep 30, 2022 | 806,000.00 |
| Jun 30, 2022 | 1.15 Mn |
| Mar 31, 2022 | 824,000.00 |
| Dec 31, 2021 | 748,000.00 |
| Sep 30, 2021 | 733,000.00 |